The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 10 rounds in the feed, most often at Series C and in AI.
IAG Capital Partners is a Venture Capital firm that leads rounds from Seed to Series D.
Venture capitalCharleston, SC 29401iagcapitalpartners.comRounds from 2022-04-26 to ~ 2026-10-05
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Universal Quantum A British startup seeking to build a working quantum computer | Series A Verified against 1 of 45 sources | $100M | ~ 2026-10-05 | [ PART ] |
Arcee AI A U.S. artificial intelligence company building frontier open-weight foundation models | Series B |
| $20M financing total |
| 2026-09-16 |
| [ PART ] |
Delos Data Delos Data sells AI infrastructure solutions specifically designed for agentic AI workloads, targeting businesses that need optimized data movement and processing. | Funding round Verified against 2 of 7 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-09-15 | [ PART ] |
Elucid Bioimaging Inc. A medical technology company using AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease | Series D Verified against 4 of 7 sources | $55M | 2026-09-02 | [ PART ] |
Cornelis Networks A high-speed networking technology company focusing on AI infrastructure | Series C Verified against 1 of 20 sources | $205M | ~ 2026-07 | [ LEAD ] |
Cognito Therapeutics Cognitotx sells a non-invasive neuroprotective therapy platform designed to evoke brain wave activity to benefit Alzheimer's patients. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $105M | 2026-03-05 | [ LEAD ] |
Ayar Labs Ayar Labs delivers co-packaged optics for AI scale-up to enable next-generation hyperscale AI infrastructure. | Series C Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $25M | 2023-05-24 | [ PART ] |
Cognito Therapeutics Cognitotx sells a non-invasive neuroprotective therapy platform designed to evoke brain wave activity to benefit Alzheimer's patients. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $73M | 2023-03-22 | [ PART ] |
Elucid Bioimaging Inc. A medical technology company using AI-powered, clinically validated software to advance precision diagnosis and treatment of cardiovascular disease | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $27M | 2022-06-22 | [ PART ] |
Ayar Labs Ayar Labs delivers co-packaged optics for AI scale-up to enable next-generation hyperscale AI infrastructure. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $130M | 2022-04-26 | [ PART ] |